Return of the Coronavirus: 2019-nCoV

Lisa E Gralinski; Vineet D Menachery

doi:10.3390/v12020135

Return of the Coronavirus: 2019-nCoV

Viruses. 2020 Jan 24;12(2):135. doi: 10.3390/v12020135.

Authors

Lisa E Gralinski¹, Vineet D Menachery^{2

3}

Affiliations

¹ Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC 27514, USA.
² Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555, USA.
³ Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, TX 77555, USA.

Abstract

The emergence of a novel coronavirus (2019-nCoV) has awakened the echoes of SARS-CoV from nearly two decades ago. Yet, with technological advances and important lessons gained from previous outbreaks, perhaps the world is better equipped to deal with the most recent emergent group 2B coronavirus.

Keywords: 2019-nCoV; MERS-CoV; SARS-CoV; Wuhan; Wuhan pneumonia; coronavirus; emerging viruses; novel CoV.

MeSH terms

Animals
Betacoronavirus* / genetics
Betacoronavirus* / isolation & purification
COVID-19
China
Communicable Diseases, Emerging
Coronavirus Infections* / epidemiology
Coronavirus Infections* / transmission
Coronavirus Infections* / virology
Disease Outbreaks*
Disease Reservoirs
Disease Susceptibility
Genome, Viral
Humans
Nucleocapsid Proteins / chemistry
Pneumonia, Viral* / epidemiology
Pneumonia, Viral* / transmission
Pneumonia, Viral* / virology
SARS-CoV-2
Severe Acute Respiratory Syndrome / epidemiology
Severe Acute Respiratory Syndrome / virology
Severe acute respiratory syndrome-related coronavirus / chemistry
Severe acute respiratory syndrome-related coronavirus / genetics
Social Media
Spike Glycoprotein, Coronavirus / chemistry
Spike Glycoprotein, Coronavirus / metabolism
Zoonoses

Substances

Nucleocapsid Proteins
Spike Glycoprotein, Coronavirus